'Hospital acquired pneumonia falls' presentation slideshows

Global Hospital-acquired Pneumonia Drugs Market to Stand at US$3.8 bn by 2020 fueled by Imminent Launches

Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being multidrug resistant, these organisms are immune to the conventional antibiotics hence difficult to treat.

170 views • 3 slides